The clone-censor-weight approach is formalized and tested via simulations before application to a breast cancer cohort comparing 2 versus 5 years of adjuvant tamoxifen, yielding estimates with substantial uncertainty.
Title resolution pending
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
fields
stat.ME 1years
2026 1verdicts
UNVERDICTED 1representative citing papers
citing papers explorer
-
Estimating treatment duration effects via clone-censor-weight: a breast cancer case study
The clone-censor-weight approach is formalized and tested via simulations before application to a breast cancer cohort comparing 2 versus 5 years of adjuvant tamoxifen, yielding estimates with substantial uncertainty.